Alvogen Pine Brook LLC et al. v. Celgene Corporation > Summary
Court Case Number IPR2018-01714
Filing Date Sep 12, 2018
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesGrace Karaffa Obermann, Tina E. Hulse, Christopher G. Paulraj
Judge Writing the Final DecisionGrace Karaffa Obermann
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Petitioner
Patent Owner
Petitioner Attorneys
4Alvogen
Attorney Name: Margaret Joyce Sampson
Baker Botts LLP
Alvogen
Attorney Name: Stephen Martin Hash
Baker Botts LLP
Alvogen
Attorney Name: Jessica S. Gritton
Baker Botts LLP
Alvogen
Attorney Name: Guido Tricot
University of Iowa
Patent Owner Attorneys
9Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Christopher J. Harnett
Jones Day
Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Daniel C. Wiesner
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: John Elsevier
Celgene
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07968569 | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione | Jun 28, 2011 |
